Financial, market and economic news

Dr. Reddy’s, RDIF Get Approval To Conduct Clinical Trial For Sputnik V COVID 19 Vaccine In India

(RTTNews) – Dr. Reddy’s Laboratories Ltd. (RDY) and Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, announced that they have received approval from the Drug Control General of India or DCGI to conduct an adaptive phase 2/3 human clinical trial for Sputnik V vaccine in India. This will be a multi-center and randomized…

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy